Wall Street analysts expect Cooper Companies Inc (NYSE:COO) to announce $2.97 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Ten analysts have issued estimates for Cooper Companies’ earnings, with the lowest EPS estimate coming in at $2.92 and the highest estimate coming in at $3.11. Cooper Companies posted earnings per share of $2.65 during the same quarter last year, which indicates a positive year over year growth rate of 12.1%. The firm is expected to issue its next earnings results on Thursday, December 6th.

On average, analysts expect that Cooper Companies will report full year earnings of $11.62 per share for the current year, with EPS estimates ranging from $11.56 to $11.79. For the next financial year, analysts anticipate that the company will post earnings of $12.25 per share, with EPS estimates ranging from $12.02 to $12.75. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that cover Cooper Companies.

Cooper Companies (NYSE:COO) last posted its earnings results on Thursday, August 30th. The medical device company reported $3.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.07 by ($0.07). The company had revenue of $660.00 million during the quarter, compared to analysts’ expectations of $653.44 million. Cooper Companies had a net margin of 5.23% and a return on equity of 17.53%.

COO has been the subject of several recent analyst reports. Zacks Investment Research downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Thursday, August 16th. BMO Capital Markets raised their price target on Cooper Companies from $280.00 to $285.00 and gave the stock an “outperform” rating in a report on Friday, August 31st. Oppenheimer set a $270.00 price target on Cooper Companies and gave the stock a “hold” rating in a report on Friday, August 31st. Raymond James lowered their price target on Cooper Companies from $275.00 to $270.00 and set an “outperform” rating for the company in a report on Tuesday, June 5th. Finally, ValuEngine downgraded Cooper Companies from a “hold” rating to a “sell” rating in a report on Wednesday, June 6th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $270.78.

NYSE COO traded up $5.10 during trading on Tuesday, hitting $264.76. The company’s stock had a trading volume of 267,300 shares, compared to its average volume of 424,077. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The company has a market cap of $12.92 billion, a PE ratio of 26.91, a P/E/G ratio of 2.10 and a beta of 0.67. Cooper Companies has a fifty-two week low of $216.47 and a fifty-two week high of $267.98.

In related news, Director Allan E. Rubenstein sold 1,500 shares of Cooper Companies stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.37, for a total transaction of $398,055.00. Following the completion of the sale, the director now owns 3,068 shares of the company’s stock, valued at $814,155.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel G. Mcbride sold 10,310 shares of Cooper Companies stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $264.44, for a total value of $2,726,376.40. Following the sale, the chief operating officer now directly owns 38,705 shares of the company’s stock, valued at approximately $10,235,150.20. The disclosure for this sale can be found here. Insiders have sold 81,005 shares of company stock valued at $20,492,936 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the stock. Signaturefd LLC purchased a new position in Cooper Companies during the first quarter valued at approximately $144,000. Archford Capital Strategies LLC purchased a new position in Cooper Companies during the first quarter valued at approximately $156,000. First Allied Advisory Services Inc. purchased a new position in Cooper Companies during the first quarter valued at approximately $200,000. GWM Advisors LLC purchased a new position in Cooper Companies during the second quarter valued at approximately $200,000. Finally, IFM Investors Pty Ltd purchased a new position in Cooper Companies during the first quarter valued at approximately $208,000. 97.06% of the stock is owned by hedge funds and other institutional investors.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Average Daily Trade Volume – ADTV

Get a free copy of the Zacks research report on Cooper Companies (COO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.